Dyslipidemia: REsidual and Mixed Abnormalities IN spite of Statin therapy: The Dyslipidemia REMAINS Study: A multicenter, prospective, observational study of lipid profiles and treatment patterns at presentation and after 12 weeks of statin therapy among Indian adults presenting with first coronary event - REMAINS

Merck Sharp and Dohme0 个研究点目标入组 850 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Currently admitted with a confirmed diagnosis of first acute coronary event
•(STEMI/NSTEMI/Unstable Angina).
•- Access to medical records covering the entire study period, and availability of data
•required for the study
•- Potential to collect blood sample within 24 hours of onset for symptoms.
•- Considered for initiation/maintenance/modification of statin therapy before discharge
•from hospital.
•- Willing to comply with the study requirements.

•- Patients who are already participating in a clinical trial or any type of other clinical study involving therapeutic intervention or otherwise failing to consent to interview
•- Patients with known inherited disorder of lipoprotein metabolism
•- Patients with history of hypothyroidism, nephrotic syndrome, chronic alcoholism, Cushing syndrome

发起方

Merck Sharp and Dohme